LMAT

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Dollar change -0.45
Percentage change -0.54	%

Peers: ABT ISRG JNJ BSX EW MDT SYK COO HOLX XRAY

| Held by: IJR VTI IWM SDVY VXF IJT IWO SPSM VIG IHI

Index	RUT	P/E	43.14	EPS (ttm)	1.93	Insider Own	8.88%	Shs Outstand	22.55M	Perf Week	-0.02%
Market Cap	1.88B	Forward P/E	33.88	EPS next Y	2.46	Insider Trans	-0.75%	Shs Float	20.56M	Perf Month	-16.45%
Income	44.04M	PEG	3.45	EPS next Q	0.50	Inst Own	95.00%	Short Float	5.70%	Perf Quarter	-9.89%
Sales	219.86M	P/S	8.56	EPS this Y	15.87%	Inst Trans	2.20%	Short Ratio	5.59	Perf Half Y	-6.49%
Book/sh	14.96	P/B	5.58	EPS next Y	10.16%	ROA	9.80%	Short Interest	1.17M	Perf Year	26.66%
Cash/sh	13.29	P/C	6.28	EPS next 5Y	12.49%	ROE	13.87%	52W Range	62.39 - 109.58	Perf YTD	-9.41%
Dividend Est.	0.66 (0.79%)	P/FCF	50.67	EPS past 5Y	16.99%	ROI	8.46%	52W High	-23.83%	Beta	0.88
Dividend TTM	0.68 (0.81%)	Quick Ratio	11.02	Sales past 5Y	13.55%	Gross Margin	66.63%	52W Low	33.79%	ATR (14)	2.94
Dividend Ex-Date	Mar 13, 2025	Current Ratio	12.85	EPS Y/Y TTM	44.78%	Oper. Margin	23.81%	RSI (14)	39.78	Volatility	2.42% 3.60%
Employees	664	Debt/Eq	0.55	Sales Y/Y TTM	13.63%	Profit Margin	20.03%	Recom	2.09	Target Price	105.62
Option/Short	Yes / Yes	LT Debt/Eq	0.54	EPS Q/Q	29.56%	Payout	33.10%	Rel Volume	0.77	Prev Close	83.92
Sales Surprise	-0.31%	EPS Surprise	-0.55%	Sales Q/Q	13.98%	Earnings	Feb 27 AMC	Avg Volume	209.62K	Price	83.47
SMA20	-1.04%	SMA50	-10.31%	SMA200	-8.52%	Trades		Volume	73,129	Change	-0.54%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-28-25	Downgrade	Oppenheimer	Outperform → Perform
Feb-28-25	Downgrade	Barrington Research	Outperform → Mkt Perform
Feb-13-25	Initiated	Wells Fargo	Equal Weight	$95
Oct-15-24	Initiated	Cantor Fitzgerald	Neutral	$96
Aug-02-24	Resumed	Lake Street	Buy	$85 → $105
May-31-24	Resumed	ROTH MKM	Buy	$100
Apr-26-24	Upgrade	Stifel	Hold → Buy	$59 → $75
Feb-06-24	Resumed	KeyBanc Capital Markets	Sector Weight
Oct-23-23	Initiated	JMP Securities	Mkt Outperform	$60
Sep-06-23	Initiated	Oppenheimer	Outperform	$70
Aug-03-23	Downgrade	Jefferies	Buy → Hold	$63 → $67
May-03-23	Upgrade	Barrington Research	Mkt Perform → Outperform	$62
Oct-28-22	Downgrade	Barrington Research	Outperform → Mkt Perform
Sep-16-21	Initiated	Jefferies	Buy	$70
Feb-12-21	Initiated	KeyBanc Capital Markets	Sector Weight
Mar-16-20	Upgrade	Sidoti	Neutral → Buy
Oct-24-19	Upgrade	Lake Street	Hold → Buy	$40
Oct-24-19	Downgrade	First Analysis Sec	Strong Buy → Outperform	$37 → $40
Oct-14-19	Upgrade	First Analysis Sec	Outperform → Strong Buy	$37
Jul-25-19	Upgrade	First Analysis Sec	Neutral → Outperform	$29 → $37

Show Previous Ratings

Mar-25-25 12:45PM	3 Reasons Growth Investors Will Love LeMaitre (LMAT) (Zacks)
Mar-22-25 12:31AM	Dividend Champion, Contender, And Challenger Highlights: Week Of March 23 (SeekingAlpha)
Mar-20-25 09:05AM	Invesco Health Care Fund Q4 2024 Commentary (SeekingAlpha)
09:00AM	Precision Optics Appoints Joseph P. Pellegrino, Jr. to Board of Directors (GlobeNewswire)
Mar-13-25 09:35AM	Down -15.37% in 4 Weeks, Here's Why LeMaitre (LMAT) Looks Ripe for a Turnaround (Zacks)
05:06PM	Loading…
Mar-03-25 05:06PM	LeMaitre to Participate at Upcoming Investor Conferences in March (GlobeNewswire)
12:00PM	LeMaitre (LMAT) Upgraded to Buy: Here's What You Should Know (Zacks)
Feb-28-25 02:40AM	LeMaitre Vascular Inc (LMAT) Q4 2024 Earnings Call Highlights: Strong Sales Growth and ... (GuruFocus.com) -8.07%
Feb-27-25 06:45PM	LeMaitre Vascular (LMAT) Meets Q4 Earnings Estimates (Zacks)
05:47PM	LeMaitre: Q4 Earnings Snapshot (Associated Press Finance)
04:32PM	LeMaitre (NASDAQ:LMAT) Misses Q4 Sales Targets, Stock Drops 11% (StockStory)
04:05PM	LeMaitre Q4 2024 Financial Results (GlobeNewswire)
Feb-26-25 08:05AM	What To Expect From LeMaitres (LMAT) Q4 Earnings (StockStory)
07:33AM	Earnings To Watch: LeMaitre Vascular Inc (LMAT) Reports Q4 2024 Result (GuruFocus.com)
Feb-25-25 02:52PM	Medtronic Stock Gets IBD Rating Lift (Investor's Business Daily)
03:15PM	Loading…
Jan-27-25 03:15PM	LeMaitre Will Announce Fourth Quarter 2024 Earnings Results February 27, 2025 (GlobeNewswire)
Dec-16-24 11:28PM	LeMaitre Vascular Prices $150 Million Convertible Senior Notes (GlobeNewswire) -8.53%
07:57AM	LeMaitre Vascular Announces Proposed Convertible Senior Notes Offering (GlobeNewswire)
Dec-11-24 02:59PM	Inari Medical Stock Gets RS Rating Upgrade (Investor's Business Daily)
Dec-03-24 02:51PM	Novocure Stock Earns 96 RS Rating (Investor's Business Daily)
Nov-25-24 05:20PM	LeMaitre to Participate at Upcoming Investor Conferences in December (GlobeNewswire)
Nov-01-24 04:47PM	LeMaitre to Participate at Upcoming Investor Conferences in November (GlobeNewswire) +7.34%
11:02AM	LeMaitre Vascular Inc (LMAT) Q3 2024 Earnings Call Highlights: Robust Sales Growth and ... (GuruFocus.com)
Oct-31-24 05:20PM	LeMaitre Vascular (LMAT) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
04:15PM	LeMaitre: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	LeMaitre Q3 2024 Financial Results (GlobeNewswire)
Oct-15-24 04:34PM	LeMaitre Will Announce Third Quarter 2024 Earnings Results October 31, 2024 (GlobeNewswire)
Oct-09-24 03:52PM	LeMaitre Vascular Inc (LMAT) Q2 2024 Earnings Call Highlights: Strong Growth Across Key Metrics ... (GuruFocus.com)
Sep-23-24 12:00PM	All You Need to Know About LeMaitre (LMAT) Rating Upgrade to Strong Buy (Zacks)
Sep-16-24 12:28PM	LeMaitre Vascular (LMAT) Surged Due to Robust Global Markets (Insider Monkey)
04:54PM	Loading…
Aug-27-24 04:54PM	LeMaitre to Participate at Upcoming Investor Conferences in September (GlobeNewswire)
Aug-16-24 01:47AM	Robust Quarterly Result Lifted LeMaitre Vascular (LMAT) in Q2 (Insider Monkey)
Aug-06-24 12:00PM	LeMaitre (LMAT) Upgraded to Strong Buy: Here's Why (Zacks)
Aug-01-24 05:55PM	LeMaitre Vascular (LMAT) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
04:51PM	LeMaitre: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	LeMaitre Q2 2024 Financial Results (GlobeNewswire)
Jul-16-24 05:26PM	LeMaitre Will Announce Second Quarter 2024 Earnings Results August 1, 2024 (GlobeNewswire)
Jun-21-24 12:00PM	LeMaitre (LMAT) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
May-21-24 05:16PM	LeMaitre to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-20-24 12:00PM	All You Need to Know About LeMaitre (LMAT) Rating Upgrade to Strong Buy (Zacks)
May-08-24 07:02PM	Insider Sale: President and Director David Roberts Sells Shares of LeMaitre Vascular Inc (LMAT) (GuruFocus.com)
05:21PM	Lemaitre Vascular Insider Sold Shares Worth $9,314,501, According to a Recent SEC Filing (MT Newswires)
May-03-24 11:28AM	LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q1 2024 Earnings Call Transcript (Insider Monkey) +11.16%
11:21AM	Barrington Boosts Price Target on LeMaitre Vascular to $79 From $69, Keeps Outperform Rating (MT Newswires)
May-02-24 09:55PM	LMAT Stock Earnings: LeMaitre Vascular Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:25PM	LeMaitre Vascular (LMAT) Q1 Earnings and Revenues Top Estimates (Zacks)
05:42PM	LeMaitre Vascular Inc (LMAT) Q1 2024 Earnings: Surpasses Analyst Revenue Forecasts (GuruFocus.com)
05:26PM	LeMaitre: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	LeMaitre Q1 2024 Financial Results (GlobeNewswire)
Apr-26-24 06:34AM	Stifel Upgrades LeMaitre Vascular to Buy From Hold, Adjusts Price Target to $75 From $59 (MT Newswires)
Apr-19-24 11:42AM	LeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024 (GlobeNewswire)
Mar-26-24 04:52PM	LeMaitre to Present at the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-05-24 12:00PM	LeMaitre Vascular (LMAT) is a Great Momentum Stock: Should You Buy? (Zacks)
Mar-01-24 04:37PM	LeMaitre to Participate at Upcoming Investor Conferences in March (GlobeNewswire)
Feb-29-24 12:00PM	LeMaitre (LMAT) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Feb-28-24 12:08PM	Q4 2023 LeMaitre Vascular Inc Earnings Call (Thomson Reuters StreetEvents) +14.41%
09:39AM	LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-27-24 05:43PM	LeMaitre: Q4 Earnings Snapshot (Associated Press Finance)
05:32PM	LeMaitre Vascular Inc (LMAT) Reports Robust Q4 2023 Results with Significant Sales and Net ... (GuruFocus.com)
04:05PM	LeMaitre Q4 2023 Financial Results (GlobeNewswire)
Feb-20-24 10:00AM	LeMaitre Vascular (LMAT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Feb-13-24 10:37AM	LeMaitre Will Announce Fourth Quarter 2023 Earnings Results February 27, 2024 (GlobeNewswire) -5.24%
Jan-11-24 02:31PM	LeMaitre to Present at the 26th Annual Needham Growth Conference (GlobeNewswire)
Dec-13-23 03:06AM	Insider Sell: Chairman and CEO George Lemaitre Sells 22,288 Shares of LeMaitre Vascular Inc (LMAT) (GuruFocus.com)
Dec-11-23 11:06PM	LeMaitre Vascular Inc's CEO George Lemaitre Sells Shares: An Insider Analysis (GuruFocus.com)
Dec-05-23 10:25AM	Sidoti Events, LLC's Virtual December Small-Cap Conference (ACCESSWIRE)
Nov-10-23 09:55AM	How Much Upside is Left in LeMaitre (LMAT)? Wall Street Analysts Think 25.24% (Zacks)
Nov-03-23 04:23PM	LeMaitre to Participate at Upcoming Investor Conferences in November (GlobeNewswire)
Nov-02-23 04:20PM	LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q3 2023 Earnings Call Transcript (Insider Monkey)
11:42AM	Q3 2023 LeMaitre Vascular Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-01-23 07:11PM	LeMaitre Vascular Inc (LMAT) Reports 21% Sales Growth in Q3 2023 (GuruFocus.com)
05:45PM	LeMaitre: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	LeMaitre Q3 2023 Financial Results (GlobeNewswire)
Oct-23-23 11:40AM	PETQ or LMAT: Which Is the Better Value Stock Right Now? (Zacks)
Oct-17-23 05:00PM	LeMaitre Will Announce Third Quarter 2023 Earnings Results November 1, 2023 (GlobeNewswire)
Sep-26-23 09:56AM	Prestige Consumer (PBH) Stock Rallies 20% in a Year: Here's Why (Zacks)
Sep-21-23 04:21PM	LeMaitre to Present at the 2023 Cantor Global Healthcare Conference (GlobeNewswire)
Sep-01-23 05:40AM	Looking for Dividend Growth? Buy This Little-Known Healthcare Stock (Motley Fool)
Aug-26-23 07:35AM	2 Healthcare Stocks That Could Help Make You a Fortune (Motley Fool)
Aug-15-23 05:21AM	Q2 2023 Aziyo Biologics Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-12-23 08:04AM	LeMaitre Vascular, Inc. (NASDAQ:LMAT) Pays A US$0.14 Dividend In Just Three Days (Simply Wall St.)
Aug-09-23 08:37AM	Heres Why LeMaitre Vascular (LMAT) Outperformed in Q2 (Insider Monkey)
Aug-03-23 07:05AM	Here's Why We Think LeMaitre Vascular (NASDAQ:LMAT) Might Deserve Your Attention Today (Simply Wall St.) -11.56%
Aug-02-23 01:44PM	LeMaitre Vascular Inc: A Strong Contender in the Medical Devices Industry with a GF Score of 84 (GuruFocus.com)
06:57AM	Q2 2023 LeMaitre Vascular Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-01-23 05:45PM	LeMaitre Vascular (LMAT) Q2 Earnings and Revenues Beat Estimates (Zacks)
04:41PM	LeMaitre: Q2 Earnings Snapshot (AP Finance)
04:05PM	LeMaitre Q2 2023 Financial Results (GlobeNewswire)
Jul-31-23 05:52PM	LeMaitre to Present at Upcoming Investor Conferences in August (GlobeNewswire)
Jul-17-23 05:40PM	LeMaitre Will Announce Second Quarter 2023 Earnings Results August 1, 2023 (GlobeNewswire)
Jul-12-23 11:40AM	ABT vs. LMAT: Which Stock Should Value Investors Buy Now? (Zacks)
Jun-28-23 03:53PM	3 Micro-Cap Stocks to Buy Now for Gigantic Growth Potential (InvestorPlace)
Jun-21-23 08:00PM	LMAT: What does Argus have to say about LMAT? (Argus Research)
Jun-19-23 09:36AM	Beat the Dow Jones With This Unstoppable Dividend Stock (Motley Fool)
Jun-15-23 06:12AM	Strength Seen in Zimmer (ZBH): Can Its 3.8% Jump Turn into More Strength? (Zacks)
Jun-13-23 08:00AM	Sidoti Events, LLC's Virtual June Small-Cap Conference (ACCESSWIRE)
Jun-06-23 05:15PM	LeMaitre to Present at Upcoming Investor Conferences in June (GlobeNewswire)
May-31-23 12:00PM	LeMaitre (LMAT) Upgraded to Strong Buy: Here's Why (Zacks)
May-27-23 09:14AM	LeMaitre Vascular, Inc. (NASDAQ:LMAT) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock? (Simply Wall St.)
May-17-23 10:07AM	Is This Healthcare Stock a Buy for Dividend Growth Investors? (Motley Fool)

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kamke Trent G	Senior V. P., Operations	Mar 14 '25	Option Exercise	36.92	2,709	100,006	3,753	Mar 14 04:53 PM
Kamke Trent G	Senior V. P., Operations	Mar 12 '25	Option Exercise	23.56	2,009	47,332	7,573	Mar 14 04:53 PM
Kamke Trent G	Senior V. P., Operations	Mar 13 '25	Sale	79.66	4,520	360,073	1,044	Mar 14 04:53 PM
Kamke Trent G	Senior V. P., Operations	Mar 12 '25	Sale	82.12	2,009	164,979	5,564	Mar 14 04:53 PM
TRENT G KAMKE	Officer	Mar 13 '25	Proposed Sale	79.66	4,520	360,074		Mar 13 04:26 PM
Kamke Trent G	Officer	Mar 12 '25	Proposed Sale	82.12	2,009	164,979		Mar 12 05:24 PM
Roberts David B	President and Director	Mar 07 '25	Option Exercise	35.48	2,818	99,983	17,976	Mar 11 04:34 PM
Jasinski Lawrence J	Director	Mar 04 '25	Sale	92.00	3,142	289,064	2,607	Mar 06 05:16 PM
LeMaitre George W	Officer	Mar 05 '25	Proposed Sale	89.46	200,000	17,892,000		Mar 05 12:46 PM
SHADAN MARTHA	Director	Feb 28 '25	Option Exercise	0.00	1	0	1,936	Mar 04 07:32 PM
Roush John A	Director	Feb 28 '25	Option Exercise	0.00	1	0	2,916	Mar 04 07:30 PM
Ross Bridget A	Director	Feb 28 '25	Option Exercise	0.00	1	0	2,916	Mar 04 07:25 PM
O'Connor John James	Director	Feb 28 '25	Option Exercise	0.00	1	0	57,301	Mar 04 07:23 PM
Jasinski Lawrence J	Director	Feb 28 '25	Option Exercise	0.00	1	0	5,749	Mar 04 07:20 PM
Kamke Trent G	Senior V. P., Operations	Feb 28 '25	Option Exercise	0.00	2	0	5,384	Mar 04 07:14 PM
Pellegrino Joseph P JR	Chief Financial Officer	Feb 28 '25	Option Exercise	0.00	5	0	9,769	Mar 04 07:10 PM
Roberts David B	President and Director	Feb 28 '25	Option Exercise	0.00	5	0	15,361	Mar 04 07:04 PM
LeMaitre George W	Chairman and CEO	Feb 28 '25	Option Exercise	0.00	11	0	1,892,831	Mar 04 06:53 PM
Jasinski Lawrence J	Director	Mar 04 '25	Proposed Sale	92.00	3,142	289,064		Mar 04 04:49 PM
LeMaitre George W	Chairman and CEO	Dec 20 '24	Option Exercise	0.00	53	0	1,891,792	Dec 26 04:14 PM
Roberts David B	President and Director	Dec 20 '24	Option Exercise	0.00	17	0	14,657	Dec 26 04:13 PM
Pellegrino Joseph P JR	Chief Financial Officer	Dec 20 '24	Option Exercise	0.00	17	0	9,248	Dec 26 04:12 PM
Kamke Trent G	Senior V. P., Operations	Dec 20 '24	Option Exercise	0.00	9	0	5,129	Dec 26 04:11 PM
Jasinski Lawrence J	Director	Dec 12 '24	Option Exercise	0.00	6	0	5,544	Dec 13 06:01 PM
Jasinski Lawrence J	Director	Dec 11 '24	Option Exercise	0.00	6	0	5,538	Dec 13 06:01 PM
Roberts David B	President and Director	Dec 12 '24	Option Exercise	0.00	22	0	15,034	Dec 13 06:00 PM
Roberts David B	President and Director	Dec 11 '24	Option Exercise	0.00	18	0	15,208	Dec 13 06:00 PM
Pellegrino Joseph P JR	Chief Financial Officer	Dec 12 '24	Option Exercise	0.00	22	0	9,827	Dec 13 05:59 PM
Pellegrino Joseph P JR	Chief Financial Officer	Dec 11 '24	Option Exercise	0.00	18	0	10,099	Dec 13 05:59 PM
O'Connor John James	Director	Dec 12 '24	Option Exercise	0.00	6	0	57,096	Dec 13 05:59 PM
O'Connor John James	Director	Dec 11 '24	Option Exercise	0.00	6	0	57,090	Dec 13 05:59 PM
Ross Bridget A	Director	Dec 12 '24	Option Exercise	0.00	6	0	2,711	Dec 13 05:57 PM
Ross Bridget A	Director	Dec 11 '24	Option Exercise	0.00	6	0	2,705	Dec 13 05:57 PM
Roush John A	Director	Dec 12 '24	Option Exercise	0.00	6	0	2,711	Dec 13 05:56 PM
Roush John A	Director	Dec 11 '24	Option Exercise	0.00	6	0	2,705	Dec 13 05:56 PM
LeMaitre George W	Chairman and CEO	Dec 12 '24	Option Exercise	0.00	52	0	1,893,055	Dec 13 05:56 PM
LeMaitre George W	Chairman and CEO	Dec 11 '24	Option Exercise	0.00	40	0	1,893,650	Dec 13 05:56 PM
SHADAN MARTHA	Director	Dec 12 '24	Option Exercise	0.00	6	0	1,731	Dec 13 05:54 PM
Kamke Trent G	Senior V. P., Operations	Dec 12 '24	Option Exercise	0.00	10	0	5,298	Dec 13 05:53 PM
Kamke Trent G	Senior V. P., Operations	Dec 11 '24	Option Exercise	0.00	7	0	5,376	Dec 13 05:53 PM
SHADAN MARTHA	Director	Dec 09 '24	Option Exercise	0.00	1	0	1,725	Dec 11 09:27 PM
Roush John A	Director	Dec 09 '24	Option Exercise	0.00	1	0	2,699	Dec 11 09:24 PM
Ross Bridget A	Director	Dec 09 '24	Option Exercise	0.00	1	0	2,699	Dec 11 09:22 PM
O'Connor John James	Director	Dec 09 '24	Option Exercise	0.00	1	0	57,084	Dec 11 09:21 PM
Jasinski Lawrence J	Director	Dec 09 '24	Option Exercise	0.00	1	0	5,532	Dec 11 09:17 PM
Kamke Trent G	Senior V. P., Operations	Dec 09 '24	Option Exercise	0.00	2	0	5,446	Dec 11 09:14 PM
Pellegrino Joseph P JR	Chief Financial Officer	Dec 09 '24	Option Exercise	0.00	4	0	10,336	Dec 11 09:11 PM
Roberts David B	President and Director	Dec 09 '24	Option Exercise	0.00	4	0	15,359	Dec 11 09:08 PM
LeMaitre George W	Chairman and CEO	Dec 09 '24	Option Exercise	0.00	9	0	1,894,142	Dec 11 09:04 PM
Kamke Trent G	Senior V. P., Operations	Dec 02 '24	Option Exercise	0.00	2	0	4,563	Dec 04 05:07 PM
Pellegrino Joseph P JR	Chief Financial Officer	Dec 02 '24	Option Exercise	0.00	12	0	8,821	Dec 04 05:04 PM
Roberts David B	President and Director	Dec 02 '24	Option Exercise	0.00	12	0	14,126	Dec 04 05:02 PM
LeMaitre George W	Chairman and CEO	Dec 02 '24	Option Exercise	0.00	32	0	1,889,486	Dec 04 04:59 PM
O'Connor John James	Director	Nov 25 '24	Option Exercise	35.48	7,500	266,100	56,663	Nov 27 05:16 PM
LeMaitre George W	Chairman and CEO	Nov 22 '24	Option Exercise	39.03	2,818	109,987	1,889,454	Nov 26 04:15 PM
Jasinski Lawrence J	Director	Nov 20 '24	Sale	103.50	198	20,493	5,111	Nov 22 04:22 PM
Ross Bridget A	Director	Nov 15 '24	Option Exercise	30.00	3,750	112,500	6,028	Nov 19 06:05 PM
Ross Bridget A	Director	Nov 15 '24	Sale	101.47	3,750	380,512	2,278	Nov 19 06:05 PM
Ross Bridget A	Director	Nov 15 '24	Proposed Sale	101.47	3,750	380,512		Nov 15 05:25 PM
SHADAN MARTHA	Director	Nov 13 '24	Option Exercise	47.19	1,070	50,493	2,770	Nov 15 05:01 PM
SHADAN MARTHA	Director	Nov 13 '24	Sale	103.37	1,466	151,547	1,304	Nov 15 05:01 PM
SHADAN MARTHA	Director	Nov 13 '24	Proposed Sale	103.37	1,466	151,548		Nov 13 06:29 PM
Roberts David B	President and Director	Aug 13 '24	Option Exercise	35.01	3,063	107,221	17,177	Aug 15 06:48 PM
Roberts David B	President and Director	Aug 13 '24	Sale	82.07	3,063	251,380	14,114	Aug 15 06:48 PM
Roberts David B	Officer	Aug 13 '24	Proposed Sale	82.07	3,063	251,387		Aug 13 06:13 PM
Kamke Trent G	Senior V. P., Operations	Aug 05 '24	Option Exercise	31.30	182	5,697	4,743	Aug 07 04:37 PM
Kamke Trent G	Senior V. P., Operations	Aug 05 '24	Sale	81.82	182	14,891	4,561	Aug 07 04:37 PM
LeMaitre George W	Chairman and CEO	Jul 16 '24	Sale	86.69	57,372	4,973,791	1,900,956	Jul 18 06:22 PM
LeMaitre George W	Chairman and CEO	Jul 15 '24	Sale	86.27	27,030	2,331,908	1,958,328	Jul 16 04:20 PM
LeMaitre George W	Chairman and CEO	Jul 12 '24	Sale	86.07	12,976	1,116,844	1,985,358	Jul 16 04:20 PM
Ross Bridget A	Director	May 16 '24	Option Exercise	30.00	5,500	165,000	7,778	May 20 04:35 PM
Ross Bridget A	Director	May 16 '24	Sale	77.99	5,500	428,945	2,278	May 20 04:35 PM
LeMaitre George W	Chairman and CEO	May 14 '24	Sale	76.80	40,968	3,146,371	1,998,334	May 15 04:11 PM
LeMaitre George W	Chairman and CEO	May 13 '24	Sale	76.42	35,826	2,737,687	2,043,302	May 15 04:11 PM
LeMaitre George W	Chairman and CEO	May 06 '24	Sale	75.70	68,906	5,216,013	2,133,428	May 08 04:51 PM
LeMaitre George W	Chairman and CEO	May 07 '24	Sale	75.51	46,300	3,496,061	2,087,128	May 08 04:51 PM
LeMaitre George W	Chairman and CEO	May 08 '24	Sale	75.30	8,000	602,427	2,079,128	May 08 04:51 PM
Roberts David B	President and Director	May 06 '24	Sale	75.62	5,025	379,990	14,114	May 08 04:35 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Lemaitre Vascular Inc

Upgrade your FINVIZ experience